Open AccessPatterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Author(s) -
Robert H.I. Andtbacka,
Merrick I. Ross,
Igor Puzanov,
Mohammed Milhem,
Frances A. Collichio,
Keith A. Delman,
Thomas T. Amatruda,
Jonathan S. Zager,
Lee D. Cranmer,
Eddy C. Hsueh,
Lisa Chen,
Mark Shilkrut,
Howard L. Kaufman
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/my37-j082
Subject(s) - medicine , melanoma , oncolytic virus , clinical trial , oncology , complete response , phases of clinical research , dermatology , cancer research , cancer , chemotherapy